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ABSTRACT 
JESSICA T. DEFRANK: Longitudinal Study of the Influence of False-Positive 
Mammography Results on Psychological Outcomes and Subsequent Screening 
Behavior 
(Under the direction of Noel Brewer, PhD) 
 
If screened regularly, over one-half of U.S. women will have abnormal 
mammography results that require additional follow-up but in which cancer is not 
detected (false-positive result). This dissertation presents and tests a model, 
informed by theoretical and empirical evidence, of the relationship between receipt 
of false-positive mammography results and adherence to subsequent 
mammography screening.  To test study hypotheses, I analyzed longitudinal data 
(n=2406), gathered through medical claims records and telephone interviews, as 
part of the PRISM (Personally Relevant Information on Screening Mammography) 
intervention trial to increase repeat mammography adherence among insured North 
Carolina women.  About 8% of women received false-positive mammography results 
within 14 months of their interviews. Among women who said their physicians had 
not advised them to get mammograms in the past year, those who received false-
positive results were more likely to have no subsequent mammogram on record 
compared to women whose results were normal (18% vs. 7%, OR=3.17, 95% 
CI=1.30,7.71).  However, among women who reported physician recommendations, 
receipt of false-positive results was not associated with adherence to subsequent 
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screening. Receipt of false-positive results was associated with greater breast 
cancer worry (p<.001), the belief that mammography test results were less accurate 
(p=.003), and thinking more about the benefits of regular screening (p<.001), 
regardless of physician recommendations. In mediation analyses, none of these 
variables explained the association between false-positive test results and 
subsequent screening behavior. Findings suggest that women who receive false-
positive mammography results, coupled with lack of physician recommendations for 
screening, are at risk for non-adherence to future screening. Abnormal 
mammograms that do not result in a cancer diagnosis are opportunities for 
physicians to emphasize the importance of regular screening. Findings provided only 
partial support for the proposed model, perhaps due to characteristics of the PRISM 
study design, where all women received annual reminders for their mammograms 
and received mammograms prior to study enrollment. 
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CHAPTER 1: A MODEL OF THE INFLUENCE OF FALSE-POSITIVE 
MAMMOGRAPHY RESULTS ON SUBSEQUENT SCREENING 
 
Inherent in any screening exam is the possibility for false-positive test results. 
Given ongoing efforts to increase regular use of medical screening, the growing 
number of screening tests becoming available to patients, and emergence of new 
technologies that improve existing tests’ sensitivity for detecting disease while 
increasing false alarms1 false-positive results are becoming ever more common. 
They present a significant public health concern because of their demonstrated 
impact on well-being and behavior.2,38 While decades of empirical research have 
investigated psychosocial consequences of false-positive mammogram results,2-7,38 
a theoretically-informed understanding of how they influence return for breast cancer 
screening is lacking. The purpose of this chapter is to present a model of how false-
positive mammography results influence subsequent mammography screening. 
While this model may be applicable to other types of false-positive test results, I 
focus on the example of screening mammography because false-positive results on 
screening mammography exams are a common experience,8 and the 
preponderance of research on psychological and behavioral effects of false-positives 
comes from the mammography literature. 
Breast cancer is the most commonly diagnosed non-skin cancer among U.S. 
women with an estimated 194,000 new breast cancer cases in 2009 and 40,000 
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deaths.9 Mammography is the single most effective method of detecting breast 
cancer early, and results of numerous studies show it reduces breast cancer 
morbidity and mortality.10-12 Despite these benefits, false-positive mammography 
results are common8 and can have lasting effects on women.2 
For the purpose of this dissertation, I define a false-positive as an abnormal 
mammogram requiring any form of further follow-up in women not found to have 
breast cancer within the next year. This broad definition of false-positives is 
consistent with current behavioral research.2 Between 6% and 15% of screening 
mammograms in the U.S. are abnormal; most of these are false-positives.13-15 About 
one-half of U.S. women aged 40-75 can expect to have a false-positive 
mammogram result if screened biennially over 10 years,8 and this rate should 
increase with annual mammography use. U.S. rates of abnormal, and thus false-
positive mammograms, are higher than those of any other country that promotes 
regular breast cancer screening, yet U.S. women die from breast cancer at rates 
similar to those of other countries.16 
In the absence of clear benefit from so many false-positive mammography 
results, the question of harms becomes more pressing. Consequences of false-
positive mammograms include substantial financial costs associated with follow-up 
testing, estimated to be over $100 million annually in the U.S. alone.17 Two recent 
meta-analyses showed that false-positive results can affect women’s well-being and 
future screening behavior.2,38  Findings from meta-analyses also offer potential 
insight into what a plausible theory might look like. The theory must account for 
psychological processes that increase likelihood of return for screening after a false-
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positive experience, as typically found for U.S. studies. The model would also have 
to account for psychological processes that have the opposite effect on return for 
screening, as typically found for European and Canadian mammography studies. 
Although several system-level factors offer potential explanations for conflicting 
geographical findings, this model focuses on psychological reactions that motivate or 
interfere with subsequent screening and is not intended to explain geographical 
differences in return for screening rates. 
This chapter first briefly introduces a theoretical model of the relationship 
between receipt of false-positive mammography results and adherence to 
subsequent mammography screening. The chapter then presents empirical and 
theoretical support for the main pathways of the model and derives novel 
predictions. I also discuss methodological considerations for statistically testing 
models clarifying the relationship between false-positive test results and behavior. 
Overview of Theoretical Model 
I propose that false-positive mammography results cause women to think 
differently about themselves and the screening test. I hypothesize that false-positive 
mammography results cause women to have elevated breast cancer-related worry, 
anxiety and perceptions of being more likely to get breast cancer in the future.  
These beliefs, in turn, motivate vigilance about future mammography screening. I 
also hypothesize that women may experience positive consequences after receipt of 
false-positive results, such as thinking more about the benefits of regular screening. 
Increased thought about the benefits of mammography should make women more 
likely to adhere to future screening. False-positive results may also cause women to 
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think differently about the accuracy of mammography screening, which in turn could 
deter them from returning for routine screening exams. Thus, the proposed model 
suggests that women’s thoughts about themselves and screening should mediate 
the relationship between receipt of false-positive mammography results and return 
for subsequent mammography screening. 
Figure 1: Model of effects of false-positive mammography results 
 
 
Influence of False-Positive Mammography Results on Return for Subsequent 
Screening 
 
Empirical studies show that false-positive results of screening tests influence 
health behaviors. Most evidence for this relationship comes from the breast cancer 
screening literature, but false-positive test results also affect return for prostate,18 
lung,19 and cervical cancer screening.20  Brewer and colleagues meta-analyses of 
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over 300,000 women from the U.S., Canada and Europe examined the effect of 
false-positive screening results on return for routine mammograms.2 Findings 
differed by geographic region. In the United States (5 studies), women who received 
false-positive results were slightly (7%) more likely to return for subsequent 
screening mammograms compared to women who had normal mammogram results. 
The largest of these studies that included over 40,000 women enrolled with the 
Vermont Mammography Registry found 63% of women with previous false-positive 
results returned for a subsequent, on-schedule screening, whereas 57% of women 
who had previous mammograms that were normal returned for subsequent, on-
schedule screening (OR=1.29; 95% CI=1.20,1.38).21 Although the effect size was 
small, this difference remained statistically significant after control for 
sociodemographic and medical variables. In contrast, studies conducted in 
European countries (5 studies) generally found no effect of false-positive 
mammograms on return for screening, though fixed effects statistical analysis of the 
data suggested a small reduction in return for screening with false-positive results.22 
Studies conducted in Canada (2 studies) also found that women who received false-
positive results were less likely to return for subsequent screening.  Studies 
published after the meta-analysis generally confirm these findings.23-25  
False-Positive Mammograms and Women’s Thoughts about Themselves 
Early studies assessing psychological effects of receiving abnormal 
mammograms generally found that large proportions of women experienced 
moderate increases in anxiety, distress, and intrusive thoughts in the short-term 
period immediately after receipt of test results. Extreme or clinically pathological 
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levels of anxiety were rare.4, 5 More recent research, both in the U.S. and abroad, 
has focused on the long-term effects of false-positive mammography results - 
commonly defined as being at least a month after doctors determine that the 
abnormal mammogram does not indicate cancer.  Meta-analyses by Salz and 
colleagues’ concluded that false-positives had a moderate but consistent effect on 
anxiety and worry about breast cancer that persisted months and even years beyond 
receipt of false-positive results.38 They also showed that women who received false-
positive test results perceived themselves to have a higher likelihood of getting 
breast cancer compared to women whose results were normal.38 
Breast cancer worry and anxiety 
False positive test results, worry and anxiety: Worry is defined for purposes of 
this research as ruminative thinking about a negative or potentially dangerous event. 
Researchers also describe worry as being a combination of “unwanted cognitive 
activity” and emotion.26 Although some use the terms worry and anxiety 
interchangeably, anxiety is a distinct phenomenon characterized by intense and 
uncontrollable emotional and physiological responses to a perceived threat.26 Thus, 
worry and anxiety both are characterized by negative cognitive and emotional 
reactions, with worry having a more deliberative cognitive quality and anxiety a less 
voluntary and more emotional quality. While worry and anxiety may be conceptually 
separable, their associations with false-positive mammogram results are similar, and 
thus I discuss them together here. 
Worry after false-positive mammography results can take many forms. 
Women might worry about getting future mammograms and the uncertainty of a 
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cancer diagnosis.27 They might also worry about potential consequences of having 
cancer, such as progressively debilitating illness or death, side-effects of cancer 
treatment, and the impact of a cancer diagnosis on one’s family, job, finances or 
quality of life.28, 29 The systematic review by Brewer and colleagues found many 
studies where false-positive mammograms caused worry about breast cancer that 
endured long after cancer had been ruled out.2 Studies by Lerman and colleagues,27, 
30 among the earliest to investigate long-term effects of false-positive mammograms, 
showed  higher levels of worry for women who received false-positive test results 
compared to those who received normal test results 3 months after the screening 
exam. Aro and colleagues followed women prospectively and found moderately-
elevated worry for women who had false-positive mammography results compared 
to those who had normal test results both at 2 and 12-months.31  A study in the 
United Kingdom, where routine screening is recommended every 3 years, found that 
women who received previous false-positive results continued to experience 
psychological distress in the month prior to their next routine screening exam.32 
Association between false-positive mammography results and breast cancer-
specific anxiety are similar to those for worry.27, 33-35 For example, Gram and 
colleagues found 29% of women who had false-positive mammography results 
reported breast cancer-related anxiety 18 months after screening compared to 13% 
of women who had normal results.33 However, many studies relying on generalized 
measures of anxiety (such as the Hospital Anxiety and Depression Scale) have not 
demonstrated long-term effects for women who received false-positive 
mammography results.34-36 These findings suggest that the anxiety experienced 
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after false-positive results is breast cancer-specific rather than general.37, 38 The 
breadth of generalized anxiety measures may prevent them from detecting important 
and breast-cancer-specific reactions to false-positive mammograms.39  
Consequences of worry and anxiety:  While worry and anxiety elicit negative 
thoughts, their influence on behavior is not necessarily deleterious. Although not 
formally embedded in commonly used models of health behavior,44 the motivating 
influence of worry parallels constructs in theories about the relationship between 
emotion and protective behavior45 and also models of stress and coping where 
emotional responses are proposed to motivate problem-focused coping.46 That is, 
theory suggests that non-pathological levels of worry and anxiety should motivate 
protective health behaviors. 
Studies also suggest that worry and anxiety are strong motivators of many 
protective health behaviors, including condom use40 and smoking cessation.41 Worry 
and anxiety about breast cancer motivates breast cancer screening in the general 
population28, 42 as well as in women who received false-positive mammography 
results. Lerman and colleagues showed that worry caused by false-positive 
mammograms had a positive, linear relationship with return for screening.27 That is, 
higher worry about breast cancer after a false-positive experience was associated 
with a greater likelihood of return for women’s next screening mammograms. The 
authors speculated that women might seek to resolve their feelings of worry through 
heightened vigilance about breast screening. While it is plausible that worry after 
false-positive test results could deter future screening,3, 28 or might have a curvilinear 
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relationship with screening,43 the research literature does not offer much support for 
these predictions.  
Perceived likelihood of disease 
False-positive test results and perceived likelihood of disease: Perceived 
likelihood of disease, sometimes referred to as perceived susceptibility or perceived 
vulnerability, refers to one’s belief about chances of personal harm. Several factors 
might influence how individuals assess their own likelihood of breast cancer or other 
diseases including their previous health experiences, health beliefs, and family 
history.47, 48 While perceptions of one’s chances for getting cancer likely is linked to 
worry about the disease, evidence suggests perceived likelihood and worry are 
distinct constructs and have unique influences on behavior.49    
Many women who have received false-positive mammography results 
perceive they have higher chances for getting breast cancer compared to those 
whose mammography results were normal. Aro and colleagues found 54% of 
women who received false-positive results described their likelihood of future 
disease as “high” or “very high” a year after the false-positive experience, higher 
than the percentage of women with normal mammogram results (43%).31 Lipkus and 
colleagues reported similar findings such that women who had false-positive 
mammography results perceived their lifetime breast cancer risk as higher than 
women whose results were normal, regardless of when the false-positive results 
occurred.50 While some women who receive false-positive test results may truly 
have a higher risk for breast cancer (Evidence suggests that women who received 
multiple breast biopsies may be at greater risk for breast cancer.),51 most abnormal 
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mammograms do not indicate substantial breast cancer risk. Thus, women’s belief 
that they have an increased likelihood for getting breast cancer because of their 
false-positive test results is often inaccurate.   
Consequences of perceived likelihood of disease: The link between perceived 
likelihood of disease and protective behavior is central to several theories of health 
behavior52 including the Health Belief Model,53 Extended Parallel Process Model54, 
and Precaution Adoption Process Model.55 These models generally propose that the 
greater people perceive their susceptibility to disease to be, the more likely they will 
be to engage in protective behavior. Theorists also argue the reverse - that behavior 
can affect perceptions of susceptibility.56 That is, perceived susceptibility might be 
both a determinant and a consequence of behavior. For example, women who do 
not receive regular mammography screening might perceive their likelihood of 
getting breast cancer as low as a way to justify their behavior.57 I will return to this 
point later, as it is an important consideration when testing for mediational effects 
(see Testing Mediational Hypotheses). 
Empirical research supports the claim that the  of being susceptible to 
disease motivates many protective behaviors, including vaccination58 and condom 
use.59 Findings from two large meta-analytic reviews found that greater perceived 
risk of breast cancer was associated with a greater likelihood of screening in the 
general population, although effect sizes were small.47, 60   
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Persistence of psychological outcomes after a false-positive test result 
Implicit in the proposed model is the assumption that psychological effects of 
false-positive mammograms, such as worry, anxiety and perceptions of risk, are 
persistent. That is, the model requires that psychological effects after false-positive 
test results persist long enough to motivate or deter subsequent mammography 
screening, which in the U.S. is typically recommended 1 year after the test that 
produced the false-positive result.61, 62, 87 One explanation for this phenomenon is 
that people may have considerable difficulty revising their beliefs once they are 
formed.  This is true even when presented with credible information contrary to those 
beliefs. 63, 64 In the context of mammography screening, abnormal test results might 
cause women to believe they have an underlying medical problem. Upon learning 
they do not have cancer, some women may have difficulty undoing thoughts of 
worry, anxiety and susceptibility to disease elicited by the abnormal test results.  
False-Positive Mammograms and Thoughts about the Screening Test 
Perceptions of screening’s accuracy 
 One potentially important but largely ignored area of research is the impact of 
false-positive results on women’s thoughts about the accuracy of screening tests. I 
focus on two objective measures of accuracy: the test’s sensitivity and positive 
predictive value. The following paragraphs provide detailed explanations of these 
concepts. However, what is more important are women’s perceptions of the test’s 
accuracy – a point I will return to later.  
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Widely-used measures of test accuracy include sensitivity and positive 
predictive value. Sensitivity is the probability an individual with disease will receive a 
positive test result. Mammography’s sensitivity is generally between 83% and 95%.13 
That is, mammography will detect between 83% and 95% of breast cancers in 
women who have the disease and undergo screening.  Another measure of 
screening accuracy, positive predictive value, is the probability a positive test result 
means there is an underlying disease. Mammography’s positive predictive value is 
very low - about 10% in the U.S.65 This means only about 10% of abnormal readings 
result in a cancer diagnosis. As shown in the hypothetical example in Table 1, the 
low positive predictive value results from there being few women with breast cancer. 
Thus, the resulting ratio of true positives to total positives (positive predictive value) 
is low. Conversely, the ratio of false-positives to total positives is high. 
Table 1: Hypothetical example of mammography accuracy 
 Have breast 
cancer 
(n=11) 
No breast 
cancer 
(n=1000) 
Abnormal mammogram 10 
(true positive) 
100 
(false-positive) 
Normal mammogram 1 
(false-negative) 
900 
(true-negative) 
Note. Sensitivity is 91% (10/11). Positive predictive value is 9% (10/110).   
False-positive test results and perceived accuracy: I hypothesize that false-
positive mammography results will influence the way women think about the 
accuracy of abnormal test results (test’s positive predictive value), but not the test’s 
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sensitivity. That is, women who have experienced false-positives should be more 
likely to think that abnormal results are often inaccurate. However, women should 
remain confident in mammography’s ability to detect breast cancer when it exists 
(test’s sensitivity) regardless of whether or not they’ve had a false-positive 
experience. This belief is rational because a false-positive result gives no 
information about whether a test is accurate in detecting cancer when it is present 
(see Table 1). False-positive results also should not influence women’s beliefs about 
the effectiveness of mammography for reducing deaths from breast cancer. That is, 
false-positive experiences should not interfere with how women value the 
importance of early detection and treatment for decreasing breast cancer deaths. 
 Few studies have explored perceptions of screening accuracy and 
effectiveness after false-positive experiences.31, 66, 67 While some evidence suggests 
that false-positives do not impact women’s perceptions of mammography’s 
sensitivity or effectiveness for reducing deaths from breast cancer,31, 66 no study has 
investigated women’s perceptions of the accuracy of abnormal test results and the 
impact of these perceptions on future use.  
Consequences of perceptions of test accuracy: Perceptions of a screening 
test’s accuracy should be associated with its use. Research shows that women who 
believe mammography’s sensitivity is high are more likely to use it.68 I hypothesize 
that women who believe abnormal test results are less accurate might avoid 
subsequent screening, although no study has tested this hypothesis. This may be 
because, women who believe abnormal test results are inaccurate may have 
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feelings of distrust about the test or the medical system.29 Studies show that medical 
mistrust is associated with underutilization of health care services.69, 70 
The hypothesis that perceptions of test accuracy should influence use of 
mammography is similar to the perceived efficacy construct in the Extended Parallel 
Process Model (EPPM).54 EPPM defines “perceived response efficacy” as the belief 
about whether or not a response (e.g., return for routine mammography screening) 
can effectively address a health threat (e.g., breast cancer).  EPPM posits that 
decisions to seek protective behaviors in the presence of a health threat hinge, in 
part, upon the availability of an effective response. Perceived response efficacy 
could tap into women’s perceptions of mammography’s accuracy. That is, women 
who believe abnormal test results are inaccurate might perceive return for screening 
as an ineffective response to their breast cancer threat and thus will avoid future 
screening. What is unique about perceived response efficacy in the context of this 
research is that the protective response individuals are contemplating (return for 
mammography screening) is the same behavior that caused the breast cancer threat 
(false-positive mammography result).  
Positive consequences of false-positive mammography results 
False-positive test results and thinking about the benefits of screening: Few 
studies have explored the possible positive effects of having false-positive 
mammograms. Some evidence suggests that false-positive experiences cause 
women to think more about the benefits of regular screening.50, 71, 72 Commonly 
reported benefits to getting regular mammograms are that they offer the possibility of 
early detection and provide “peace of mind.” Studies by Lipkus50 and Pisano72 found 
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that while women who received false-positive mammography results had greater 
breast cancer-related distress, they also thought more about the benefits of 
mammography compared to women who received normal test results. Meta-
analyses also support the presence of both positive and negative reactions to false-
positive mammograms.38  
Consequences of thinking about the benefits of screening: The increased 
consideration of the potential benefits of screening should make these beliefs more 
accessible in memory and thus improve their ability to affect subsequent behavior.73, 
74 Studies show that women who understand more about the benefits of 
mammography are more likely to be screened regularly.75-77 As a result, many 
interventions designed to increase mammography use focus on having women think 
about the test’s benefits.75, 78, 79 
Theory also suggests that thought about the benefits of mammography may 
serve as a coping response for women who experienced false-positive test results. 
Models of stress and coping conceptualize “coping responses” as thoughts and 
behaviors individuals use to offset or overcome adversity and manage stressful 
aspects of their environment.46 Problem-focused coping involves using adaptive 
strategies, such as problem solving and information seeking, to manage a stressful 
situation. Problem-focused coping may be one strategy individuals use to offset 
negative feelings caused by a false-positive test result. That is, women who have 
had false-positive mammograms might counterbalance the worry and anxiety about 
getting breast cancer elicited by their experiences by thinking more about how they 
might benefit from regular screening. 
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Predictions from the Model 
The proposed model allows us to test several predictions about how false-
positive mammography results should affect subsequent breast cancer screening. 
1. False-positive mammography results should affect subsequent 
screening behavior.  Findings from U.S. studies suggest that women who 
receive false-positive mammography results should be more likely to return 
for subsequent mammography screening.2 
 
2. Thoughts elicited by a false-positive experience should mediate the 
relationship between receipt of false-positive test results and adherence 
to subsequent screening. Women whose previous mammograms were 
false-positive will have elevated breast cancer-related worry and will believe 
they are more likely to get breast cancer compared to women whose previous 
mammograms were normal. In turn, these thoughts will motivate vigilance 
about regular screening. Women might also think more about the benefits of 
regular mammography after receipt of false-positive results, which in turn 
would also increase their likelihood of return for screening.  No published 
studies have examined these mediational pathways.    
 
3. Beliefs about mammography’s accuracy should suppress the 
relationship between receipt of false-positive mammography results and 
adherence to subsequent screening. Women who receive false-positive 
mammography results may believe that abnormal test results are less 
accurate. This belief might cause women to distrust screening, off-setting the 
 17 
 
positive influences of worry, perceived likelihood of disease and thoughts 
about the test’s benefits. Few studies have examined the prediction that false-
positive test results affect perceptions of test accuracy, and no published 
study has examined suppression effects. 
Moderating Influences  
While I hypothesize that false-positive mammography results influence 
subsequent screening - as mediated by thoughts about the person and thoughts 
about the test - there may also be important subgroup differences. Decisions to 
return for subsequent mammography screening after receiving false-positive results 
may be conditional upon various factors, including women’s educational level, 
literacy, income, and interactions with health care providers, to name a few (see 
Figure 2).  I classify these factors as “predisposing” or “enabling” factors as is 
commonly done in health behavior research.80, 81 Predisposing factors in this model 
refer to socio-demographic characteristics, such as education level, that might 
modify the way that false-positive test results affect how women think about 
themselves or the screening test. Enabling factors refer to financial or health care 
resources that, when unavailable, might deter women from acting on feelings elicited 
by false-positive results, breaking the mediational chain.  
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Figure 2: Moderating factors on association between false-positive 
mammography results and subsequent screening 
 
Financial and health-care resources 
Abnormal mammogram results require potentially costly and time consuming 
follow-up procedures. One U.S. study estimated that for every $100 spent on 
screening mammograms on a population level, an additional $30 was spent on 
follow-up procedures due to abnormal test results8, although actual costs borne by 
individual women was not known. U.S. women who receive false-positive 
mammography results are likely burdened with some costs from follow-up testing 
(although this may be less of an issue in other countries where costs are not a 
barrier to mammography screening). Other costs associated with false-positive test 
results may include missed work hours, transportation, childcare needs or other 
inconveniences.82 Therefore, women who receive false-positive test results and lack 
sufficient financial resources may be less likely to act on thoughts and feelings 
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elicited by their test result compared to women who receive false-positives but have 
no financial hardship.  
Similarly, women who receive false-positive test results and do not have a usual 
source of health care, or opportunities to communicate with their physicians about 
their false-positive experiences, may be less likely to comply with future 
mammography screening compared to women who receive false-positive results but 
have these resources. Physicians are important sources of information for women 
contemplating the benefits and risks of screening.83, 84 Thus, physician 
recommendations may prompt women who receive false-positive results to act on 
feelings of worry and anxiety, thus facilitating return for future screening. Additional 
predictions of the model are: 
4. The effects of false-positive mammography results on subsequent 
screening depend on women’s ability to understand the results. While 
not a specific aim of this study, women with lower education levels might 
understand less about the complexities of screening and their test results. As 
a result, they might be less likely to experience worry, perceive themselves as 
more likely to get breast cancer, or think about the benefits of screening, 
breaking the mediational chain. Similar predictions could be made for factors 
such as numeracy and health literacy. 
 
5. The effects of false-positive mammography results on subsequent 
screening depend on the presence of financial and health care 
resources.  Women who lack financial or health care resources may not 
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show the pattern of mediation proposed in the previous models. Lack of these 
resources may interfere with women’s ability to act on thoughts and feelings 
elicited by a false-positive experience, breaking the mediational chain.  
Testing Mediational Hypotheses 
The model of false-positive test results proposes several mediational 
hypotheses. That is, the model seeks to clarify the causal pathways through which a 
false-positive test result exerts its effect on future behavior. While researchers have 
used a variety of study designs to test mediational hypotheses, strong tests of 
mediation should establish a temporal chain among predictor, mediator and outcome 
variables.85 The predictor (X) should occur before the mediator variable (M), and M 
should occur before the outcome (Y). Because measurement of constructs is 
unlikely to coincide with their occurrence, researchers should take special care in 
understanding the limitations and challenges inherent in the approach they choose. 
In this section, I use the example of false-positive mammography results and 
adherence to subsequent screening to illustrate several key considerations when 
testing the model’s mediational hypotheses. 
Cross-sectional study designs 
Researchers sometimes test for mediation using cross-sectional study 
designs that rely on retrospective recall of constructs and behaviors. However, such 
studies usually preclude establishing a temporal timeline among variables, making 
them undesirable for testing mediational hypotheses. Thus, findings from cross-
sectional studies can only be considered as exploratory or suggestive of mediation.86  
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In the context of false-positive mammography results and return for 
screening, use of cross-sectional study design is potentially problematic because the 
outcome - Y (whether or not women returned for a subsequent screening and the 
result of that screening exam) could plausibly influence subjects’ report of potential 
mediators (M). For example, women who returned for subsequent screening 
mammograms (Y) and received normal test results may report less worry about 
breast cancer (M) compared to women who had not yet returned for screening.  
Similarly, women who had not returned for subsequent screening (Y) might minimize 
their perception of breast cancer risk (M) as a way to justify their behavior. As a 
result, effects of M on Y would be biased because of this reverse causal pathway, 
and the basis for causal inference would be seriously undermined. 
Longitudinal study designs 
Longitudinal designs are preferable for testing mediation models because 
they better allow researchers to establish a temporal timeline among variables.86 In 
the context of false-positive mammography results and return for screening, 
longitudinal designs offer many advantages, but also introduce some complexities.  
One important consideration regards the ideal timing for assessment of mediators. 
This length of time should not be so long that psychological effects of the false-
positive result would have dissipated. Studies have found false-positive test results 
impact psychological outcomes anywhere from a few weeks to 3 years after the 
false-positive experience, though effects may last even longer.2 Assessing potential 
mediators more than 3 years after the false-positive test result may not yield 
meaningful findings as effects of the false-positive result might have dissipated. A 
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related consideration is that time between the false-positive and assessment of 
mediators should not be so great such that a subsequent screening mammogram 
(Y) occur prior to assessment of the mediators (M). For example, if researchers 
allowed several years to elapse between the false-positive and assessment of 
mediators, women are likely to have returned for a routine screening by this time 
(most U.S. women are advised to return for screening 12 months after the screening 
that produced the false-positive result).61,62,87 In these cases, occurrence of Y would 
precede measurement of M. As discussed previously, this is problematic, because 
women’s return for screening (Y) would have influenced responses to questions 
regarding mediator variables (M). 
It is also possible that the degree to which false-positive test results impact 
psychological outcomes (M) will vary over time. As a result, the strength of the effect 
of X on M might not be the same for all time intervals. For studies where the 
influence of X on M might not be stationary, researchers suggest the inclusion of a 
variety of time intervals over which the mediation process unfolds.86 That is, rather 
than assessment of a time-specific mediated effect (the degree to which M at exactly 
Time 2 mediates the effect of X at exactly Time 1 on Y), researchers will be more 
interested in an overall mediated effect -  the degree to which M at any time within a 
specified window mediates the effect of false-positive test results on behavior.  
A final consideration in longitudinal mediation research is that occurrence of a 
construct might differ from when a researcher measures it.86 That is, measures of Y 
and M might actually assess conditions that began long before the occurrence of X. 
As a result, the temporality among variables could be compromised. In the context of 
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false-positive mammograms, some mediators (such as worry about breast cancer) 
will have existed prior to the occurrence of X (false-positive test result). Women may 
have worried about breast cancer even before receipt of the mammogram that 
produced the false-positive result. Therefore, prior levels of M should be controlled if 
researchers want to determine if changes in the mediating variables influence the 
outcome. Another possible scenario is that the behavior represented by Y might 
precede X. Women who consistently return for routine screenings might be more 
likely to have received false-positive test results. That is because, women who are 
screened regularly will have undergone more screening exams. They, therefore, will 
have had more opportunities for false-positive results.88 Studying a population of 
homogenous women with respect to their previous screening histories or statistical 
adjustment for previous screening behavior would control for this potential source of 
bias.  
Significance and Implications of the Research 
Understanding the influence of false-positive mammography results is 
increasingly important as we rethink screening guidelines and implement new 
screening technologies. Researchers estimate that about one-half of U.S. women 
will receive false-positive mammography results if tested regularly.8 This proportion 
should increase if women adhere to annual (rather than biennial) screening 
guidelines. Wider implementation of digital mammography might also contribute to 
higher rates of false-positive results because research suggests digital technology 
detects larger proportions of breast cancers at the expense of an increased false-
positive rate.1 A better understanding of the long-term psychological and behavioral 
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consequences of receiving false-positive results on screening exams should be a 
public health priority. While research suggests that small elevations in worry and 
anxiety elicited by false-positive experiences may be good for motivating future 
screening, these psychological effects are unnecessary and should be addressed. 
Findings from this study should have implications for intervention and will guide 
future research on other types of screening exams and behaviors. I discuss these 
implications later in the dissertation. 
  
 
CHAPTER 2: SPECIFIC AIMS AND HYPOTHESES 
 
Aim 1: To assess effects of false-positive mammography results on adherence 
to subsequent mammography screening. 
Hypothesis 1: Women whose previous mammography results were false-
positives will be more likely to obtain their subsequent, on-schedule screening 
mammograms than women whose previous mammography results were 
normal. 
Aim 2: To assess effects of false-positive mammography results on women’s 
thoughts about themselves and thoughts about the test. 
Hypothesis 2.1: Compared to women whose previous mammography results 
were normal, women whose previous mammography results were false-
positives will have more breast cancer worry. 
Hypothesis 2.2: Compared to women whose previous mammography results 
were normal, women whose previous mammography results were false-
positives will believe they are more likely than other women to get breast 
cancer. 
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Hypothesis 2.3: Compared to women whose previous mammography results 
were normal, women whose previous mammography results were false-
positives will think more about the benefits of regular mammography. 
Hypothesis 2.4: The relationship between receipt of a previous false-positive 
mammography result and beliefs about effectiveness of mammography in 
reducing deaths from breast cancer will be non-significant. 
Hypothesis 2.5: The relationship between receipt of a previous false-positive 
mammography result and perceptions of mammography’s ability to detect 
breast cancer (test’s sensitivity) will be non-significant.  
Hypothesis 2.6: Compared to women whose previous mammography results 
were normal, women whose previous mammography results were false-
positives will believe abnormal test results are less accurate (test’s positive 
predictive value). 
Aim 3: To determine if the relationship between receipt of false-positive 
mammography results and adherence to subsequent mammography 
screening is mediated by women’s thoughts about themselves and thoughts 
about the screening test.   
I state mediation hypotheses only for variables hypothesized to be associated with 
receipt of false-positive mammography results in Aim 2. 
Hypothesis 3.1: Women whose previous mammography results were false-
positives will have more breast cancer worry and, in turn, will be more likely to 
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obtain their subsequent, on-schedule screening mammograms than women 
whose previous mammography results were normal. 
Hypothesis 3.2: Women whose previous mammography results were false-
positives will believe they are more likely than other women to get breast 
cancer and, in turn, will be more likely to obtain their subsequent, on-schedule 
screening mammograms than women whose previous mammography results 
were normal. 
Hypothesis 3.3: Women whose previous mammography results were false-
positives will think more about the benefits of regular mammography and, in 
turn, will be more likely to obtain their subsequent, on-schedule screening 
mammograms than women whose previous mammography results were 
normal. 
Hypothesis 3.4: Women whose previous mammography results were false-
positives will believe abnormal test results are less accurate (test’s positive 
predictive value) which, in turn, will suppress the hypothesized positive 
relationship between receipt of false-positive mammography results and 
subsequent, on-schedule screening. 
Aim 4: To determine if financial or health care-related factors moderate the 
relationship between receipt of false-positive mammography results and 
adherence to subsequent mammography screening. 
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Hypothesis 4.1: Report of financial hardship will moderate the relationship 
between receipt of false-positive mammography results and adherence to 
subsequent screening. 
Hypothesis 4.2: Report of cost barriers to obtaining mammograms will 
moderate the relationship between receipt of false-positive mammography 
results and adherence to subsequent screening. 
Hypothesis 4.3: Receipt of physician recommendations for mammograms will 
moderate the relationship between receipt of false-positive mammography 
results and adherence to subsequent screening. 
 
  
 
CHAPTER 3: RESEARCH DESIGN AND METHODS 
  
To address the study aims, I used data from a large, prospective study of 
repeat mammography use among insured North Carolina women aged 40-75. 
Parent Study for Secondary Data Analysis 
PRISM (Personally Relevant Information about Screening Mammography), 
part of the National Institutes of Health (NIH) Health Maintenance Consortium, is a 
randomized controlled trial to increase rates of repeat mammography. Barbara K. 
Rimer, DrPH, is the principal investigator. Institutional review boards for the 
University of North Carolina School at Chapel Hill and Duke University approved the 
research study. 
Study sample and recruitment 
PRISM researchers identified potential participants through the North 
Carolina Teachers' and State Employees' Comprehensive Major Medical Plan, also 
known as the State Health Plan (SHP). DeFrank and colleagues described 
recruitment and data collection methods.89 Briefly, the sample included North 
Carolina female residents who were between the ages of 40 and 75, enrolled with 
the SHP for two or more years prior to sampling, and had recent mammograms 
within a designated time period. Researchers identified 9,087 women who met initial 
eligibility criteria. 
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PRISM study enrollment occurred between October 2004 and April 2005. 
Researchers sent invitation letters to all potential participants with instructions for 
opting out of the study. Trained telephone interviewers from Battelle Centers for 
Public Health Research and Evaluation made as many as 12 attempts to obtain 
consent and administer baseline interviews. Of those invited, 3,547 women 
completed baseline telephone interviews, 2,051 refused to participate, and 747 were 
ineligible due to answers on screening interviews (e.g., breast cancer history)(see 
Figure 3, Analytic sample). The remaining 2,742 women were of unknown eligibility 
because call attempts were exhausted (n=2,570) or their enrollment was no longer 
needed (n=172) to reach the target sample size. The range in baseline response 
rates, based on the American Association for Public Opinion Research (AAPOR) 
Standard Definitions, was 47% to 64%.90 The lower response rate excludes a portion 
of those with unknown eligibility from the response rate calculation; the higher 
response rate excludes all those with unknown eligibility. These response rates are 
typical for participation in national telephone surveys, which have declined in recent 
years.9 
Data collection 
Following consent, women completed 30-minute baseline telephone 
interviews that assessed socio-demographics and mammography-related beliefs 
and practices. Subsequent telephone interviews occurred at about 12, 24, 36 and 42 
months (see Appendix A, PRISM Data Collection Timeline) and lasted about 30 
minutes. Women who completed 36-month telephone interviews comprised the 
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analytic sample for this study. Women not reached for 12- or 24-month interviews 
were still eligible to participate in 36-month interviews.  
Intervention 
Although not the focus of this research, I describe PRISM interventions 
because it is plausible that receipt of PRISM interventions may have diminished 
effects of false-positive mammography results on key study variables. PRISM 
researchers pre-randomized women to 1 of 9 intervention strategies prior to study 
recruitment (see Appendix B, PRISM Study Design). PRISM did not include a non-
intervention control arm for ethical reasons. PRISM used a two-step intervention 
design where after delivery of a first round of interventions, women who became 
non-adherent to mammography received supplemental interventions. The first round 
of intervention involved randomization to 1 of 3 reminder types: printed enhanced 
usual care reminders, printed reminder booklets guided by behavioral theory 
(enhanced letter reminder), and automated telephone reminders. Supplemental 
interventions were a combination of printed reminder letters (priming letters) and 
telephone counseling, both tailored to women’s self-reported barriers and knowledge 
deficits regarding mammography. In addition to addressing barriers, some 
supplemental interventions also elaborated on positive consequences of getting 
regular mammograms or negative consequences of not getting regular 
mammograms. Delivery of reminders occurred 2-3 months prior to women’s 
mammography due dates. Study staff mailed priming letters approximately 3 months 
after women’s due dates (once they became overdue for their next screenings); 
counseling calls followed 2-5 weeks later. Researchers timed delivery of subsequent 
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intervention over the 4-year study period according to due dates for women’s next 
mammograms. PRISM findings showed that supplemental intervention (priming 
letters plus any form of telephone counseling) was more effective in reducing 
cumulative days of non-adherence during the 4-year study period than PRISM 
reminders only, although effect sizes were small.92  
Analytic Sample 
The analytic sample included 2,406 participants who completed 36-month 
interviews. Only the 36-month interviews included items on perceived test accuracy - 
a key study construct. Women with a previous breast cancer diagnosis did not 
participate in the interviews. The sample included respondents to 36-month 
telephone interviews (n=2,979) and excluded those who did not have recent 
mammograms in the last 14 months (n=358), were no longer members of the State 
Health Plan (n=160) and therefore information on subsequent mammography 
screening was not available, or had a breast cancer diagnosis subsequent to their 
interviews (n=55) indicating their abnormal test results were “true positives” (Figure 
3). The analytic sample included women in all PRISM intervention arms to provide 
sufficient sample sizes to detect potentially small effects.  
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Figure 3: Analytic sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measures 
Predictor 
Receipt of false-positive mammography results: The primary predictor 
variable for analyses is women’s recent mammography test result self-reported 
during 36-month interviews. The interview item states: “Since we last spoke, have 
you had a mammogram when you were told the results were not normal, but no 
cancer was found?” Response categories were Yes, No, and Don’t Know. Missing 
9,087 mailed invitation 
3,547 participants at baseline 
2,051 refused 
2,570 call attempts 
exhausted (unknown 
eligibility) 
172 enrollment no longer 
needed to reach target 
sample (unknown eligibility) 
747 deemed ineligible at 
baseline interview 
2,406 for analyses  
159 withdrew (death, 
revoke consent) 
2,979 participants at 36-month 
interviews  
358 no recent mammogram 
(within 14 months of 
interview) 
160 no longer SHP member 
55 breast cancer diagnosis 
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values were small (n=2) and were coded as No. Women did not receive this 
interview item if they reported a recent breast cancer diagnosis or if they did not 
have mammograms since their last interview date. These exclusion criteria helped to 
ensure that women’s abnormal mammograms were not true-positives and that 
occurrence of false-positive results was recent (within 14 months of the 36-month 
interviews). False-positive results occurring more than 14 months prior to the 36-
month interviews were coded as No, because a subsequent screening mammogram 
may have occurred prior to the 36-month assessments. PRISM researchers relied 
on self-report of abnormal test results, because SHP medical claims data did not 
include information about screening test results. Previous research indicates that 
self-report of abnormal mammogram results corresponds highly with medical 
records, but may be less accurate for minority or low-education groups.93  
A second predictor variable was the number of self-reported false-positive 
test results since PRISM study enrollment. This number came from responses to 12-
, 24-, and 36-month interviews and ranged from 0 to 3. I used this variable for 
exploratory analyses assessing effects of receiving multiple false-positive results. 
Outcome 
Adherence to subsequent screening mammography: The primary dependent 
variable for analyses was adherence to subsequent mammography screening. 
PRISM researchers used SHP claims information, verified by self-report for most 
women, to determine women’s previous and subsequent mammogram dates.  
Women coded as “adherent” obtained their subsequent screening mammograms 10 
to 14 months after their previous screening mammograms at 36-month interview 
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assessments. All women in the study sample had an opportunity to return for 
subsequent screening within 14 months of their previous mammograms and thus be 
adherent. Women coded as “non-adherent” either received mammograms that were 
delayed or had no subsequent mammogram on record for this study. The 10-14 
month window is consistent with previously published PRISM research.89 
Researchers chose the lower boundary of 10 months to exclude mammograms that 
were likely diagnostic or short-interval rescreening mammograms. Thus, 
mammograms occurring within 10 months of women’s previous mammograms were 
not used to determine the outcome. The upper boundary of 14 months reflects 
American Cancer Society recommendations for yearly mammograms plus a 2-month 
window for scheduling.94 At the time of the study, women who received false-positive 
mammography results typically should have returned for regular screening 1 year 
from the date of the screening exam that produced abnormal results (as opposed to 
1 year from the date of follow-up or diagnostic exams).61, 62  
Analyses used 2 versions of the adherence outcome.  A dichotomous 
outcome classified women as adherent vs. non-adherent to subsequent 
mammography screening.  A nominal outcome further classified the non-adherent 
women as either having received a subsequent but delayed mammogram or having 
no subsequent mammogram on record, thus resulting in a 3-level variable.  
Mediators 
Mediator variables come from 36-month interviews. Responses to mediator 
variables were recoded such that higher scores reflected more of the variable of 
interest (e.g., higher scores reflected more breast cancer worry). Missing values 
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were relatively uncommon and ranged from 0-4%. Missing values were not 
associated with false-positive status for any proposed mediator variable. 
Worry about breast cancer was measured with two items and combined to 
create a single continuous measure ranging in score from 2 to 9. The first item read: 
Having yearly mammograms causes you worry or anxiety about breast cancer. I 
coded responses of strongly agree as=4, somewhat agree=3, somewhat 
disagree=2, and strongly disagree=1. The second item read: How worried are you 
about getting breast cancer in your lifetime? I coded responses of not at all as =1, a 
little=2, some=3, a lot=4, a great deal=5, and refused/don’t know=missing.  
Perceived likelihood of breast cancer was measured with one item assessing 
women’s comparative perceptions of risk that read: How likely are you to get breast 
cancer in your lifetime compared to the average woman your age and risk? I coded 
responses of more likely as=3, about as likely=2, less likely=1, and refused/don’t 
know=missing. 
 Thought about the benefits of mammography was measured with a single 
item that read: In the past week, how often have you thought about the benefits you 
can gain by getting a mammogram when you are due?  I coded responses of none 
of the time as=1, a little of the time=2, a moderate amount of time=3, and most of the 
time=4.  
Perceived accuracy of mammography was measured with two items. The first 
item assessed women’s perceptions of the test’s sensitivity and read: How much do 
you trust mammograms to give accurate information about whether you have breast 
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cancer? I coded responses of not at all as=1, a little=2, a moderate amount=3, 
completely=4 and refused/don’t know=missing. The second item assessed women’s 
perceptions of the test’s positive predictive value and read: How often do you think 
an abnormal mammogram result means a woman has breast cancer? I coded 
responses of always as=4, most of the time=3, some of the time=2, rarely=1 and 
refused/don’t know=missing.  
 Perceived effectiveness of mammography was measured with one item: 
Thinking of women your age and race, how effective are mammograms for reducing 
deaths from breast cancer? I coded responses of very effective as=4, somewhat 
effective=3, somewhat ineffective=2 and very ineffective=1.  
Moderators 
 Moderator variables came from 36-month surveys. Missing values were 
uncommon and did not exceed 1% for any variable. Missing values were not 
associated with false-positive status for any proposed moderating variable. 
Financial barriers were assessed with two items and tested separately as 
potential moderators. The first item read: Without giving exact dollars, how would 
you describe your household’s financial situation right now? Responses were: after 
paying the bills, you still have enough money to buy special things as=1, you have 
enough money to pay the bills, but little spare money to buy extra or special 
things=2, you have money to pay the bills, but only because you have to cut-back on 
things=3, you are having difficulty paying the bills no matter what you do=4, and 
refused/don’t know =missing. Due to low frequency of some responses, I 
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dichotomized this variable as no financial hardship=0 (after paying the bills, you still 
have enough money to buy special things) and 1=financial hardship (other 
responses). The second item was from a list of reasons why women delay 
mammograms and read: The cost of the mammogram: Do you agree or disagree 
that this could delay your getting a mammogram. Responses were strongly agree 
as=4, somewhat agree=3, somewhat disagree=2, strongly disagree=1, and 
refused/don’t know=missing. I retained this item as a continuous variable. Missing 
values were small and did not exceed 1% for either item. 
 Physician recommendation for mammograms was assessed with a single 
item and read: In the last year, has a doctor advised you to have a mammogram? I 
coded responses as yes=1, no=0 and don’t know/refused=missing. Missing values 
on the physician recommendation variable (12; 0.5%) were not associated with 
false-positive status (p-value for Fisher’s exact test=1.00). 
Data Analysis 
I assessed effects of false-positive mammography results on adherence using 
logistic regression for the dichotomous outcome and generalized logit model (GLM) 
analyses for the 3-level nominal outcome.95 Preliminary analyses rejected the 
proportional odds assumption (p=.05), confirming that the 3-level outcome should be 
treated as a nominal rather than ordinal measure. GLM analyses first produced a 
Wald chi-square statistic for the overall association between false-positive status 
and the outcome and then produced 2 sets of regression parameters comparing 
each category of non-adherence to the adherent category. I assessed effects of 
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false-positive test results on potential mediating variables using linear regression 
and correlation analyses.  
I conducted mediation analysis using bootstrapping techniques described by 
Preacher & Hayes.96 Mediation analysis tested the hypothesis that the product of 
paths a and b (a*b) differed significantly from 0, where path a represented the 
association between the predictor and mediator variables, and path b represented 
the association between the mediator variables and outcome adjusting for the 
predictor.96, 97 In brief, bootstrapping involved resampling from the dataset and 
estimating the mediated effect thousands of times. This information was used to 
build an empirical approximation of the sampling distribution of a*b, providing bias-
corrected standard errors and 95% confidence intervals. Bootstrapping provides 
higher power to detect mediated effects compared to more traditional approaches 
(such as the Sobel test). Bootstrapping is also preferred when including covariates 
or multiple mediators. 
Tests of moderation involved inclusion of an interaction term that crossed the 
predictor variable and moderator (e.g., receipt of false-positive mammography 
result*physician recommendation for a mammogram) along with both the predictor 
and moderator variables in the regression models. Power analyses suggested that 
the available sample size was sufficient to detect potentially small effects of false-
positives on mediating variables and the outcome. Sample sizes exceeded 
recommended numbers to test for potentially small mediated effects.98  
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I conducted analyses using SAS v9.1.3. Tests were two tailed, using a critical 
alpha of .05.   
  
 
CHAPTER 4: RESULTS 
Participants 
The mean age for women in the study sample was 55 years (Table 2). Most 
women were white (88%), married (79%), and had a college education (65%). About 
one-third (31%) reported some level of financial hardship, but few reported they 
“somewhat agreed” or “strongly agreed” that cost was a barrier to future screening 
(9%). Most (70%) reported their physicians advised them to get mammograms in the 
past year. Over one-half of women (60%) were adherent to repeat mammography 
screening prior to study enrollment.  
About one-half of women (51%) reported ever having received a false-
positive mammography result prior to 36-month interview assessments. About 17% 
(403/2406) of women received false-positive mammography results since study 
enrollment (1214/2406). A small percent of women (3%) reported multiple false-
positive results since study enrollment (69/2406).  About 8% of women (184/2406) 
reported a recent false-positive result in the 14 months prior to their 36-month 
interview assessments, which is the main predictor variable for these analyses. 
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Table 2: Demographic and medical characteristics of the sample 
  
 
Total 
(n=2406) 
n(%) 
Recent 
mammogram was 
false-positive 
(n=184) 
n(%) 
Recent 
mammogram 
was normal 
(n=2222) 
n(%) p 
Age (mean) 
 
55.1 55.2 55.1 .83 
Race  
  White 
  Black 
  Asian 
  Native Hawaiian/Pacific 
Islander 
 American Indian/Alaska 
Native 
 Refused or "other" 
 
2118 (88.0) 
249 (10.4) 
8   (0.3) 
1 (0.04) 
 
24 (0.5) 
 
6 (0.3) 
 
166 (7.8) 
16 (6.4) 
0 (0.0) 
0 (0.0) 
 
1 (4.2) 
 
1 (16.7) 
 
1952 (92.2) 
233 (93.6) 
8 (100.0) 
1 (100.0) 
 
23 (95.9) 
 
5 (83.3) 
.67a 
Marital status 
  Married  
  Not married  
  Missing 
 
1910 (79.4) 
495 (20.6) 
1 (<0.1) 
 
143 (7.5) 
41 (8.3) 
0 (0.0) 
 
1767 (92.5) 
454 (91.7) 
1 (100.0) 
.55 
Education 
  ≤High school  
  Some college 
  ≥College 
  Missing 
 
358 (14.9) 
478 (19.9) 
1569 (65.2) 
1 (<0.1) 
 
27 (7.5) 
42 (8.8) 
115 (7.3) 
0 (0.0) 
 
331 (92.5) 
436 (91.2) 
1454 (92.7) 
1 (100.0) 
.57 
a 
p-value for Fisher’s exact test 
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Table 2 cont. 
 
Total 
(n=2406) 
n(%) 
Recent 
mammogram 
was false-
positive 
(n=184) 
n(%) 
Recent 
mammogram 
was normal 
(n=2222) 
n(%) p 
Financial status 
  No financial hardship 
  Some financial hardship 
  Missing 
 
1649 (68.5) 
  748 (31.1) 
      9   (0.4) 
 
120 (7.3) 
62 (8.3) 
2 (22.2) 
 
1529 (92.7) 
686 (91.7) 
7 (77.8) 
.39  
Cost a barrier 
  Strongly disagree   
  Somewhat disagree 
  Somewhat agree 
  Strongly agree 
 
2049 (85.2) 
162 (6.5) 
114 (2.7) 
81 (6.5) 
 
155 (7.6) 
12 (7.4) 
5 (4.4) 
12 (14.8) 
 
1894 (92.4) 
150 (92.6) 
109 (95.6) 
69 (85.2) 
.073a 
Doctor or provider advised 
mammogram in the past year 
  No   
  Yes 
  Missing 
 
 
721 (30.0) 
1673 (69.5) 
 12  (0.5) 
 
 
39 (5.4) 
145 (8.7) 
0 (0.0) 
 
 
682 (94.6) 
1528 (91.3) 
12 (100.0) 
.006  
Adherent to repeat screening 
prior to study enrollment 
  No 
  Yes 
 
 
962 (40.0) 
1444 (60.0) 
 
 
74 (7.7) 
110 (7.6) 
 
 
888 (92.3) 
1334 (92.4) 
.95 
 
 
 
Previously received a false-
positive result 
  No   
  Yes 
 
 
1192 (49.5) 
1214 (50.5) 
 
 
66 (5.5) 
118 (9.7) 
 
 
1126 (94.5) 
1096 (90.3) 
<.001 
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Assessment of Potential Control Variables 
Some characteristics varied by recent false-positive status (Table 2). Women 
who previously received false-positive mammography results were more likely to 
have received recent false-positive results (10%) compared to women who had not 
previously received false-positive results (6%; p<.001). However, this variable was 
not associated with adherence to subsequent screening (p=.27). Women who 
received physician recommendations for mammograms were more likely to have 
received recent false-positive results (9%) compared to women who did not receive 
physician recommendations (5%; p=.006). Physician recommendation for 
mammograms was marginally associated with adherence to subsequent screening 
(p=.06). Inclusion of physician recommendation for mammograms as a control 
variable did not change study findings. Therefore, I report bivariate relationships 
unless otherwise noted. Analyses did not control for intervention type, because 
proportions of women who reported recent false-positive mammography results did 
not differ by PRISM intervention arm (p=.15). 
Adherence to Subsequent Mammography Screening 
The following sections describe findings for the dichotomous adherence 
outcome (adherent vs. non-adherent) and nominal adherence outcome (adherent vs. 
delayed mammogram vs. no subsequent mammogram on record). As discussed 
previously, the two outcomes are computationally similar except that the nominal 
outcome expands non-adherence into two categories. I hypothesized women who 
received recent false-positive mammography results would have higher rates of 
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adherence to subsequent screening compared to women who received normal 
results (Hypothesis 1).  
Findings showed women whose previous mammography results were false-
positives were equally likely to be adherent to their subsequent screening 
mammograms (69%; 127/184) compared to women whose previous mammography 
results were normal (75%; 1667/2222) (OR=0.74, 95% CI=0.54,1.03; p=.07). I also 
tested whether categories of non-adherence (delayed mammogram vs. no 
subsequent mammogram on record) varied for women who received false-positive 
compared to normal test results and found no overall association (Wald X2=4.3; 
p=.12)(Table 3). Subsequent screening mammograms that were delayed occurred 
for 22% (40/184) of women who reported recent false-positive results and for 16% 
(355/2222) of women who reported their recent mammography results were normal. 
No subsequent screening mammogram was on record for 9% (17/184) of women 
who reported recent false-positives and for 9% (200/2222) of women who reported 
their recent mammography results were normal. The number of false-positive test 
results since study enrollment was not associated with either adherence outcome 
(p=.71 and p=.84 for dichotomous and nominal outcomes respectively). 
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Table 3: Association between false-positive status and adherence to 
subsequent screening 
 
 
Women’s Thoughts about Themselves and Thoughts about the Screening Test 
False-positive test results and thoughts about the person 
I hypothesized receipt of recent false-positive test results would be associated 
with more breast cancer-related worry (Hypothesis 2.1) and a higher perceived 
likelihood of getting breast cancer (Hypothesis 2.2). As hypothesized, women who 
received recent false-positive mammography results had more breast cancer worry 
compared to women whose mammography results were normal (r=.07; p<.001) 
(Table 4). The amount of breast cancer-related worry did not vary with the number of 
days elapsed since women’s recent mammography exam (mean 196 days) for either 
the false-positive or normal test results group (p=.97). That is, amount of worry was 
stable over time for women in both groups. Also contrary to my hypothesis, receipt of 
recent false-positives was not associated with women’s perceived likelihood of 
getting breast cancer in their lifetime (r=.01; p=.63) (Table 4).  
  
 
Adherent 
n (%) 
 
Delayed 
mammogram 
n (%) 
No subsequent 
mammogram on 
record 
n (%) 
Recent 
mammogram was 
false-positive 
 
 
127/184 (69.0) 
 
40/184 (21.7) 
 
17/184 (9.3) 
Recent 
mammogram was 
normal 
 
1667/2222 (75.0) 
 
355/2222 (16.0) 
 
200/2222 (9.0) 
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Greater number of false-positive mammography results since study 
enrollment was associated with more breast cancer-related worry (r=.10, p<.001), 
but was not associated with greater perceived likelihood of getting breast cancer 
(r=.03, p=.24).  
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Table 4: Association between false-positive status and women’s thoughts 
about themselves 
  
 
Recent 
mammogram 
was false-
positive 
(n=184) 
 
n(%) 
 
 
 
Recent 
mammogram 
was normal 
(n=2222) 
 
n(%) 
 
 
 
 
 
 
r   
 
 
 
 
 
 
p 
Breast cancer-related worry 
 
How worried are you about getting 
breast cancer in your lifetime? 
Not at all 
A little 
Some 
A lot 
A great deal 
Missing 
 
Having yearly mammograms causes 
you worry or anxiety about breast 
cancer. 
Strongly disagree 
Somewhat disagree 
Somewhat agree 
Strongly agree 
Missing 
 
 
 
 
 
22 (12.0) 
73 (39.7) 
72 (39.1) 
15 (8.2) 
2 (1.1) 
0 (0.0) 
 
 
 
 
128 (69.6) 
24 (13.0) 
20 (10.9) 
12 (6.5) 
0 (0.0) 
 
 
 
 
328 (14.8) 
1027 (46.2) 
719 (32.4) 
102 (4.6) 
43 (1.9) 
3 (0.1) 
 
 
 
 
1701 (76.6) 
281 (12.7) 
193 (8.7) 
43 (1.9) 
4 (0.2) 
.07  
 
<.001 
Perceived likelihood of getting 
breast cancer in lifetime 
 
How likely are you to get breast 
cancer in your lifetime compared to 
the average woman your age and 
race? 
Less likely 
About as likely 
More likely 
Missing 
 
 
 
  
 
  
 
39 (21.2) 
112 (60.9) 
25 (13.6) 
8   (4.3) 
 
 
 
 
 
 
 
518 (23.3) 
1338 (60.2) 
300 (13.5) 
66   (3.0) 
.01  
 
 
 
 
.63 
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False-positive test results and thoughts about the screening test 
 I hypothesized women who received recent false-positive mammography 
results would believe abnormal test results were less accurate (test’s positive 
predictive value) compared to women whose mammography results were normal 
(Hypothesis 2.6), but that false-positive status would have no effect on perceptions 
of the test’s sensitivity (Hypothesis 2.5) or effectiveness (Hypothesis 2.4). I also 
hypothesized women who received recent false-positive mammography results 
would think more about the benefits of regular screening (Hypothesis 2.3). 
As hypothesized, women who received false-positive mammography results 
believed abnormal test results were less accurate (test’s positive predictive value) 
than women who received normal test results (r= -.06; p=.003) (Table 5). Receipt of 
false-positives was not associated with thoughts about the test’s sensitivity for 
detecting disease (r=.01; p=.67) or the test’s effectiveness for reducing deaths from 
breast cancer (r=-.02; p=.34). As hypothesized, recent false-positive results also 
were associated with thinking more about the benefits of regular mammography 
(r=.07; p<.001). Commonly reported benefits for both groups of women were that 
having regular mammograms provided “peace of mind” (50%) and allowed for the 
early detection of breast cancer (27%). 
Greater number of false-positive mammography results since study 
enrollment was associated with beliefs that abnormal test results were less accurate 
(r= -.10; p<.001) and with thinking more about the benefits of regular mammography 
(r=.05; p=.021). 
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Table 5: Association between false-positive status and thoughts about the test  
  
Recent 
mammogram 
was false-
positive 
(n=184) 
n(%) 
 
 
Recent 
mammogram 
was normal 
(n=2222) 
n(%) 
 
 
 
 
 
r 
 
 
 
 
 
p 
Test’s positive predictive value 
How often do you think an abnormal 
mammogram result means a woman 
has breast cancer? 
Rarely 
Some of the time 
Most of the time 
Always 
Missing 
 
 
 
 
 
12 (6.5) 
159 (86.4) 
10 (5.4) 
2 (1.1) 
1 (0.5) 
 
 
 
 
131 (5.9) 
1686 (75.9) 
372 (16.7) 
12 (0.5) 
21 (1.0) 
-.06 
 
.003 
 
Test’s sensitivity 
How much do you trust 
mammograms to give accurate 
information about whether or not you 
have breast cancer? 
Not at all 
A little 
A moderate amount 
Completely 
Missing 
 
 
 
 
 
 
0 (0.0) 
4 (2.2) 
111 (60.3) 
68 (37.0) 
1 (0.5) 
 
 
 
 
 
4 (0.2) 
79 (3.6) 
1315 (59.2) 
820 (36.9) 
4 (0.2) 
.01 .67 
Test’s effectiveness 
Thinking of women your age and 
race, how effective are 
mammograms for reducing deaths 
from breast cancer? 
Very ineffective 
Somewhat ineffective 
Somewhat effective 
Very effective 
Missing 
 
 
 
 
 
 
3 (1.6) 
2 (1.1) 
48 (26.1) 
131 (71.2) 
0 (0.0) 
 
 
 
 
 
23 (1.0) 
10 (0.5) 
561 (25.2) 
1610 (72.5) 
18 (0.8) 
-.02 
 
.34 
 
Thought about benefits of regular 
mammograms 
In the past week, how often have you 
thought about the benefits you can 
gain by getting a mammogram when 
you are due? 
None of the time 
A little of the time 
A moderate amount of time 
Most of the time 
 
 
 
 
 
 
105 (57.1) 
39 (21.2) 
28 (15.2) 
12 (6.5) 
 
 
 
 
 
 
1483 (66.7) 
431 (19.4) 
237 (10.7) 
71 (3.2) 
.07 <.001 
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Association of Potential Mediators and Subsequent Mammography Screening 
Breast cancer-related worry was not associated with adherence to 
subsequent screening (OR=1.02, 95% CI=.95,1.10; p=.63). Individual items 
measuring breast cancer worry also were not associated with adherence to 
subsequent screening. I tested for a possible curvilinear relationship between the 
item asking women how worried they were about getting breast cancer in their 
lifetimes and the outcome, because of the potentially curvilinear pattern of 
responses. However, the quadratic term was not associated with adherence (p=.62).  
Adherence to subsequent mammography screening was not associated with 
women’s perceived likelihood of getting breast cancer (OR=1.08, 95% CI=.92,1.26; 
p=.35), thinking more about the benefits of regular screening (OR=.98, 95% CI=.88, 
1.09; p=.70) or belief in the accuracy of abnormal test results (OR=.99, 95% CI=.82, 
1.20; p=.91). Thoughts about the test’s sensitivity (OR=1.07, 95% CI=.91,1.27; 
p=.43) and effectiveness for reducing deaths from breast cancer (OR=1.08, 95% 
CI=.91,1.23; p=.40) were not associated with adherence to subsequent screening. 
Findings were the same for the nominal adherence outcome. 
Mediation 
 I hypothesized that women’s thoughts about themselves and thoughts about 
the screening test would mediate the relationship between receipt of false-positive 
test results and adherence to subsequent screening (Hypotheses 3.1-3.4). While 
receipt of a recent false-positive test result was associated with breast cancer-
related worry, beliefs about accuracy of abnormal test results and thinking about the 
benefits of regular screening, none of these variables was associated with 
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adherence to subsequent screening. Regardless, I conducted statistical tests of 
mediation, because mediation may exist in the absence of statistically significant 
pathways.99 The bootstrapped estimate of the mediated effect was not significantly 
different from 0 for worry (95% CI = -1.99, 2.16), beliefs about test accuracy (95% CI 
= -1.59,1.74), or for thinking about the test’s benefits (95% CI= -1.69,2.35). 
Bootstrapped estimates also did not differ from 0 when simultaneously including 
these variables in a single model, when controlling for baseline values of the 
mediator and outcome variables, or when controlling for physician recommendation 
for screening. Thus, none of the hypothesized variables mediated (or suppressed) 
the relationship between receipt of false-positive mammography results and 
adherence to subsequent screening. I return to these issues later in the dissertation, 
because it is possible that lack of association may have been due to characteristics 
of the PRISM study and sample. 
Moderation 
I hypothesized that financial factors would moderate the relationship between 
receipt of false-positive mammography results and adherence to subsequent 
screening (Hypotheses 4.1-4.2). Contrary to my hypothesis, reporting cost barriers 
to mammography screening or financial hardship did not moderate the relationship 
between receipt of false-positive mammography results and adherence to 
subsequent screening (p=.50 and .53 respectively). Other contextual factors did not 
moderate the relationship between receipt of a recent false-positive test result and 
adherence to subsequent screening: age (p=.51), ever having received a prior false-
positive mammography result (p=.23), adherence to regular mammography 
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screening prior to study enrollment (p=.99), and education (p=.41). Findings were 
also null for the nominal adherence outcome. 
As hypothesized, influence of recent false-positive mammography results on 
adherence to subsequent screening was conditional upon receipt of a physician’s 
recommendation for mammography screening (Hypothesis 4.3). This modifying 
effect was statistically significant for the nominal adherence outcome (p=.02), but not 
for the dichotomous adherence outcome (p=.38). Thus, only findings for the nominal 
outcome are reported here. Post-hoc analysis showed that among women who 
reported physician recommendations, receipt of recent false-positive results was not 
associated with adherence to subsequent screening (p=.054). However, among 
women who said their physicians had not advised them to get mammograms, those 
who received false-positives were more likely to have no subsequent mammogram 
on record compared to women who received normal test results (18% vs 7%, 
OR=3.17, 95% CI=1.30,7.71)(Table 6). Thus, receipt of a physician recommendation 
for mammograms buffered the negative effect of false-positive mammography 
results on return for subsequent screening.  
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Table 6: Association between false-positive status and adherence to 
subsequent screening by physician recommendation for mammograms 
 
a Comparison of no subsequent mammogram vs. adherent: OR=0.73, 95% CI= 0.37,1.42; 
p=.054 
b Comparison of no subsequent mammogram vs. adherent: OR= 3.17, 95% CI=1.30,7.71; 
p=.038 
 
Sensitivity Analyses 
I conducted sensitivity analyses to assess whether receipt of PRISM 
intervention might have diminished the influence of false-positive test results on 
adherence. I could not test this hypothesis directly, because all PRISM participants 
received study interventions. Researchers did not include a non-intervention control 
group for ethical reasons. However, study interventions ranged in intensity from 
simple reminders (mailed or automated telephone messages) to reminders plus 
individually-tailored priming letters and telephone counseling. Women randomized to 
a PRISM “control” arm received reminders only whereas the remainder received 
  
 
Adherent 
n (%) 
 
Delayed 
mammogram 
n (%) 
No subsequent 
mammogram on 
record 
n (%) 
Physician 
recommendation for a 
mammogram a 
Recent mammogram 
was false-positive 
 
Recent mammogram 
was normal 
 
 
 
 
101/145 (69.7) 
 
 
1137/1540 (73.8) 
 
 
 
 
34/145 (23.4) 
 
 
248/1540 (16.1) 
 
 
 
 
10/145 (6.9) 
 
 
155/1540 (10.1) 
 
No physician 
recommendation for a 
mammogram b 
Recent mammogram 
was false-positive 
 
Recent mammogram 
was normal 
 
 
 
 
 
26/39 (66.7) 
 
 
530/682 (77.7) 
 
 
 
 
 
6/39 (15.4) 
 
 
107/682 (15.7) 
 
 
 
 
 
7/39 (18.0) 
 
 
45/682 (6.6) 
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reminders and tailored interventions if they became overdue for their mammograms. 
It is possible that the effect of false-positive test results on subsequent adherence 
was weaker for those randomized to receive the tailored interventions, because 
these interventions were more intensive and designed to help women overcome 
barriers to screening. Previous PRISM analyses showed that tailored interventions 
were more effective in reducing non-adherence compared to reminder interventions 
over the 4-year study period.92 However, the interaction between false-positive 
status and intervention type (simple reminders vs. tailored interventions) on 
adherence to subsequent screening was not statistically significant (p=.97), 
indicating that the influence of false-positive results on adherence was similar 
regardless of the intensity of PRISM intervention. Also, effects of false-positives on 
adherence to subsequent screening were null for the PRISM “control” arm (n=1024; 
p=.23).  
While sample sizes for the described analyses were large (n=2406), I 
addressed the possible lack of statistical power to detect associations by conducting 
additional analysis using a continuous adherence outcome measure. This measure 
counted the number of days between recent and subsequent screening 
mammograms (mean=457 days, SD=183; range 305-993). Consistent with the 
previously reported findings, the effect of false-positives on number of days between 
screenings was null (p=.23) as were associations between proposed mediating 
variables and days between screenings. The interaction with physician 
recommendations for mammograms remained statistically significant (p=.04).  
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Findings also did not differ by method of imputation (mode or median) for missing 
data on proposed mediating or moderating variables. 
  
 
CHAPTER 5: DISCUSSION 
 
 My dissertation had two overarching goals. The first was to describe a model, 
guided by theory and empirical evidence, explaining the relationship between receipt 
of false-positive mammography results and adherence to subsequent screening. 
While influence of false-positive mammography results on future screening behavior 
and psychological outcomes is well-established, a theoretically-informed model 
clarifying these relationships is lacking. The second aim of this dissertation was to 
statistically test pathways of the model using longitudinal data from the PRISM 
(Personally Relevant Information on Screening Mammography) study and to assess 
for mediational and moderation effects. The purpose of this chapter is to describe 
where study findings support and deviate from the model described earlier in this 
dissertation. I also discuss study limitations, strengths, and implications for 
intervention and future research. 
Do False-Positive Mammography Results Influence Future Screening? 
Contrary to my hypothesis, receipt of false-positive mammography results did 
not influence return for subsequent screening in this study. Among women who 
received false-positive mammography results, 69% returned for screening within 14 
months compared to 75% of women whose mammography results were normal. 
This finding conflicts somewhat with a recent meta-analysis showing that, among 
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U.S. women, receipt of false-positive mammography results typically motivates 
adherence to future screening.2 
 U.S. studies that have assessed this relationship - conducted between 1991 
and 2003 - found that false-positives either had no effect or a small positive effect on 
subsequent mammography use. The slight, but negative null effect for this study is 
notable for not having been documented previously in any U.S. study. Rather, this 
trend is more consistent with Canadian and some European findings where false-
positives have been shown to interfere with subsequent mammography screening.2 
Given slight declines in mammography use for some groups of U.S. women100 
coupled with controversy concerning the benefits and harms of screening for breast 
cancer,101 monitoring the effects of false-positive test results should remain a public 
health priority. 
While not the focus of this dissertation, I briefly speculate why findings from 
this study more closely resemble those from European studies. Many European 
countries have screening programs that automatically schedule women into 
appointments to attend their regular mammograms and send reminders for these 
appointments. European programs thus require women to “opt-out” of 
mammography screening should they choose not to attend.  In the U.S., women 
must “opt-in” to undergo regular screening; no national program automatically invites 
women to attend regular mammography screening. In essence, PRISM created an 
“opt-out” program for study participants similar to that of European systems. 
Researchers sent PRISM participants annual reminders for their mammograms and 
contacted women who became delayed by telephone. While “opt-out” programs that 
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invite women to attend screening produce higher rates of mammography 
compliance,102 it is also plausible that women in these programs might have more 
distrust or disappointment in mammography screening if they receive false-positive 
results, which in turn might deter future screening. 
While false-positive mammography results had no overall effect on 
subsequent screening, interesting subgroup differences emerged. Among women 
who said their physicians had not advised them to get mammograms, receipt of 
false-positive test results interfered with their return for subsequent screening. For 
women who lacked physician recommendations, 67% who received false-positives 
returned for timely subsequent screenings compared to 78% of women who 
received normal test results. This finding suggests that abnormal mammograms that 
do not result in a cancer diagnosis can be opportunities for physicians to stress the 
importance of regular screening. Women who do not receive this advice could be at 
risk for not returning for future mammography screening. While we might expect that 
most patients and physicians communicate about the benefits and harms of breast 
cancer screening following a false-positive experience, few women report having 
such conversations.103 I discuss implications for intervention later in this chapter. 
Influence of false-positive mammography results on subsequent screening 
did not vary by other factors, including presence of financial barriers, women’s age, 
education level, whether they received prior false-positive mammography results 
and whether they were already adhering to regular mammography screening prior to 
study enrollment. It is plausible that women who have lower incomes might be less 
likely to return for timely screening after receiving false-positives because of the 
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costs and inconveniences associated with follow-up testing. While study findings did 
not lend support for this hypothesis, all women in the sample were insured, and few 
reported cost barriers to getting their mammograms. Testing this hypothesis in a 
more socioeconomically diverse population might yield different findings. Other 
research suggests that financial costs associated with follow-up testing can be 
substantial.8, 104 In the U.S. alone, such costs are estimated to exceed $100 million 
annually.17 However, the extent to which women are burdened with these financial 
costs is not known and should be the topic of further investigation. In addition to 
financial costs, women who undergo follow-up testing for abnormal test results are 
likely burdened with other costs, including missed time from work, meeting 
transportation and childcare needs, and other inconveniences.29, 82  
Do False-Positive Mammography Results Affect the Way Women Think about 
Themselves or the Screening Test? 
Findings showed limited support for other proposed pathways of the model. 
Receipt of false-positive mammography results influenced the way women thought 
about themselves. Women who received false-positives worried more about breast 
cancer compared to women `who received normal test results -  even about a year 
after receiving the “all clear” from cancer. Moreover, levels of breast cancer worry 
were higher for women who received multiple false-positive results. The finding that 
false-positive mammography results cause breast cancer-related anxiety, worry and 
distress that endures over the long-term is well-documented in the research 
literature.2, 27, 31, 38, 50 Studies both in the U.S. and abroad consistently have shown 
moderate but reliable elevations in breast cancer-specific distress anywhere from a 
few weeks to 3 years after cancer had been ruled out. While elevations in breast 
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cancer-related distress are rarely pathological or require medical attention, these 
symptoms are unnecessary byproducts of screening and should be minimized.  
Breast cancer-related worry did not influence future mammography use in this 
study. This peculiar finding conflicts with research suggesting that worry about 
breast cancer increases vigilance about mammography screening.27, 28, 42 and with 
theorists’ positions that non-pathological worry motivates self-protective behaviors.26, 
45 There also was no support for an alternative hypothesis positing a curvilinear 
relationship between worry and screening (that is, some research suggests that 
moderate levels of worry motivate screening, whereas extremely high or low levels 
of worry deter future screening).43  Rather than conclude that worry about breast 
cancer has no influence on screening behavior, I attribute this lack of association to 
characteristics of the study sample and design, discussed later in this chapter. 
 Study findings supported the hypothesis that false-positive mammography 
results change the way women think about the screening test. While receipt of false-
positive test results had no effect on beliefs about mammography’s sensitivity for 
detecting breast cancer, women who received false-positive mammograms believed 
abnormal test results were less accurate. That is, these women were more likely to 
understand that abnormal test results do not necessarily indicate cancer (the test’s 
positive predictive value). This belief is rational because women’s false-positive 
experiences would have debunked the misperception that positive test results mean 
cancer is present. Whether or not these beliefs reflected distrust or dissatisfaction 
with screening could not be addressed by our study. It is plausible that feelings of 
distrust would inhibit women who receive false-positives from returning for future 
 62 
 
screening exams, although this hypothesis remains untested. Qualitative research 
by Padgett and colleagues suggests that some women who receive false-positive 
mammography results leave the screening experience feeling suspicious or 
distrusting of the health care system.29 While our study did not assess influence of 
distrust on screening per se, we found that believing abnormal test results are often 
inaccurate had no effect on future screening. This finding might suggest that receipt 
of false-positive test results caused women to have more realistic expectations 
about the accuracy of abnormal test results. Research shows people generally are 
willing to accept false-positive results and that this experience does not dampen 
enthusiasm for cancer screening.105 Given the paucity of research assessing 
perceptions of test accuracy and feelings of distrust after false-positive screening 
results, this topic warrants further research. 
Findings showed positive consequences of receiving a false-positive results, 
which is consistent with other research.38, 50, 71, 106, 107 Women in this study who 
received false-positives spent more time thinking about the benefits of regular 
mammography, such as the possibility for early detection of breast cancer and 
feeling “peace of mind” when results are normal. Increased thought about the 
benefits of regular mammography use may have served as a coping response for 
women who experienced false-positive test results. Models of stress and coping 
conceptualize “problem-focused coping” as thoughts and behaviors individuals use 
to offset adversity, such as information seeking or problem solving.46 Thus, women 
who had false-positive mammography results might have counterbalanced the worry 
and anxiety elicited by this experience by thinking more about the potential positive 
 63 
 
aspects of regular screening. While the increased consideration of mammography’s 
benefits did not influence return for screening in this study, several other studies 
show that women who understand and think about the benefits of screening exams 
are more likely to get them.75-77 
 Contrary to my hypothesis, receipt of false-positive mammography results did 
not cause women to believe they had a greater likelihood of getting breast cancer. 
This finding conflicts with a recent meta-analysis that found false-positive test results 
had a small but significant effect on perceived likelihood of disease.38 That is, 
women who received false-positive mammography results generally believed they 
had a higher chance of getting breast cancer compared to women who received 
normal test results, although effects were often small. Discrepancy between our 
study’s findings and previous research might be due to differences in measurement. 
Our study used a measure of “comparative risk” that assessed how women 
perceived their own likelihood of getting breast cancer compared to other women of 
their age and race. However, previous research has relied heavily on measures of 
perceived absolute risk, that is, how likely women think they are to get breast cancer 
in their lifetimes (for example, on a scale from 1-5). A study by Lipkus and 
colleagues used both types of perceived risk measures and showed that receipt of 
false-positive mammography results was associated with perceptions of absolute 
risk, but not comparative risk.50 Other research also supports the claim that 
perceived susceptibility measures are not interchangeable.108  
 64 
 
Is There Support for the Model? 
 Consistent with the proposed model, false-positive mammography results 
affected both the way women thought about themselves and about the test. That is, 
receipt of false-positive mammography results caused elevated breast cancer worry 
(thoughts about the person), coupled with the belief that abnormal test results were 
less accurate and increased thought about the benefits of regular screening 
(thoughts about the test). Findings also showed support for the presence of both 
negative and positive reactions to false-positives. While the majority of studies on 
false-positives have assessed negative reactions, such as worry, anxiety and 
distress, fewer have explored potential positive reactions to this experience.  
Findings from this study do not offer support for a key study hypothesis that 
thoughts and feelings elicited by false-positive experiences explain return for 
subsequent screening. While it is possible that the model simply is incorrect, this 
interpretation is implausible given the large body of empirical and theoretical 
evidence supporting the association of these beliefs and health behaviors, including 
mammography screening. I turn to alternative explanations for why there was a lack 
of association among these key variables.  As described in other sections of this 
dissertation, women who participated in PRISM all had previous mammograms (per 
the study’s eligibility criteria) and agreed to take part in a 4-year trial where they 
would receive yearly telephone interviews and study interventions. It is possible that 
women who agreed to participate in PRISM were already highly motivated about 
getting regular mammograms and, therefore, perceptions of worry and test accuracy 
would have had little influence on decisions to get mammograms. Another 
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explanation is that PRISM participants received yearly reminders for their 
mammograms, and some received telephone counseling designed to help them 
overcome their barriers to screening. Thus, receipt of PRISM interventions may have 
diminished the effect of key variables on adherence to subsequent screening. I was 
unable to test this hypothesis directly, because PRISM did not include a non-
intervention control group for ethical reasons. However, sensitivity analyses showed 
that the influence of false-positive results on return for screening was similar 
regardless of the intensity of PRISM intervention. A worthwhile area of future 
research would be to test a theoretical model of false-positives outside the context of 
an intervention trial. 
Other Limitations and Considerations 
 PRISM researchers did not have access to medical records to determine 
which mammograms were false-positives. Rather, this study relied on women’s self-
reports of whether they had a recent mammogram that was abnormal but where no 
cancer was found. While research suggests that self-report is a highly accurate 
method of determining whether people had false-positive screening results,93 it is 
possible that rates of false-positives were under-reported slightly in this study. Some 
women may not have known or understood that their test results were abnormal. 
Yet, false-positive rates for this study (8%) were very similar to national averages.13-
15 Proportions of women who inaccurately reported receipt of normal test results that 
were in fact false-positives should not have differed for women who were 
subsequently adherent or non-adherent to screening. Thus, it is unlikely that 
underreporting of false-positive mammograms would have biased study findings. 
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 Information on the type of follow-up women underwent for abnormal test 
results (e.g., rescreen, ultrasound, biopsy etc.) was not available for this study. This 
information may have been useful, because some research suggests that invasive 
follow-up procedures, such as biopsy, cause stronger effects on women’s 
perceptions of worry and risk compared to less invasive procedures or 
rescreening.27, 30, 106 However, regardless of the type of follow-up procedure, women 
who receive false-positive mammography results generally report worse 
psychological outcomes compared to women whose mammograms are normal. 
Also, studies show that rates of return for regular screening after receipt of false-
positive results are the same regardless of type of follow-up.27 Therefore, it is 
unlikely that control for type of follow-up women received for their abnormal test 
results would have influenced key findings. 
 Another limitation is that the study population was insured, highly educated 
and predominately white. Generalizability of findings to non-insured populations and 
those with diverse socioeconomic and racial/ethnic backgrounds should be the topic 
of future research.  
Study Strengths 
 The greatest strength of this study was use of prospective data to test 
theoretically-driven hypotheses about the relationship between false-positive test 
results, psychological outcomes and subsequent screening behavior. Although study 
findings did not show evidence of mediational effects, I discuss methodological 
considerations when testing for mediation and recommend cutting-edge statistical 
techniques for future researchers seeking to clarify the relationship between false-
 67 
 
positive test results and future health behavior. Other strengths included a large 
population-based sample and access to health claims information to confirm most 
women’s mammogram dates. 
 Implications for Future Research 
 Expanding the proposed model to other behaviors and populations would be 
a worthwhile area of future research.  For example, effects elicited by false-positive 
mammography results for women are likely to be similar to those experienced by 
men undergoing screening for prostate cancer. False-positive prostate cancer 
screening test result (PSAs) likely influence men’s perceptions of cancer risk, worry, 
and perceptions of test accuracy, although these topics have received little research 
attention.18 However, unlike mammography screening, the one published study on 
this topic suggests men who receive false-positive results on PSAs are less likely to 
return for subsequent prostate cancer screening compared to men whose results are 
normal.18 While it is possible that perceptions of test inaccuracy or distrust might 
explain this finding, other factors, such as the risk of sexual side effects that can 
result from biopsy procedures for positive PSAs, should be considered.  Another 
population of future interest is breast cancer patients who have survived their 
disease and are undergoing regular screening and surveillance. False-positive 
results on routine mammography exams likely have a tremendous impact on cancer 
survivors’ thoughts, well-being and screening behavior, although no research I am 
aware of has explored these issues.  
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Implications for Intervention  
False-positive mammography results cause small but reliable elevations in 
breast cancer-related distress that can endure for months or even years after cancer 
has been ruled out. While some might argue that a little worry can serve as a good 
motivator for future adherence to screening, clinicians have a responsibility to 
minimize distress caused by false-positive test results. As one physician commented 
“experience from daily life teaches us that nothing is so corrosive and enervating as 
a persisting uncertainty about the possibility of serious illness or upset.”109 
Research from a large controlled trial shows that by offering immediate follow-
up and reading of test results, women’s anxieties after abnormal mammograms can 
be greatly reduced.110 This may be, because women receiving same day follow-up 
for abnormal test results may not have time for anxiety and worry to settle in. 
However, same day follow-up for abnormal test results is far from common practice. 
Clinics that cannot provide these services could intervene by providing women with 
written information about the recall process,111 or with counseling from nurses after 
receipt of abnormal test results that addresses the benefits and harms of regular 
screening.112 Both strategies have been shown to reduce women’s concerns. 
Findings from our research suggest that women who receive multiple false-positive 
mammography results might deserve more careful clinical attention, because they 
experience higher levels of breast cancer-related distress.  
False-positive mammography results, coupled with a lack of communication 
between patients and their physicians about these results, could lead to non-
compliance with future screening. Primary care physicians and staff are important 
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sources of information about breast cancer screening and are well-positioned to 
provide advice and reassurance after false-positive results. Best practices in 
communicating with patients who have had false-positive test results about the 
balance of benefits and harms of regular screening are needed. 
Conclusion 
 To conclude, understanding potential harms from mammography is important 
as we contemplate new screening guidelines. If screened regularly, as many as one-
half of U.S. women will have false-positive mammography results in their lifetimes. 
Although most experts still agree that the benefits of regular mammography use 
outweigh its negative consequences, despite current controversy, minimizing 
distress caused by false-positive results should be a public health priority. 
Interventions to alleviate these concerns, as well as the role of physicians in 
promoting future screening after a false-positive experience, should be a focus of 
future intervention research. 
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APPENDIX B: PRISM Study Design 
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letter reminder (ELR)
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